IE Smith
Impact in
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Mitch Dowsett (7 shared papers)S.E. Ashley (1 shared paper)K. Priest (2 shared papers)MC Nicolson (2 shared papers)J M Shneerson (2 shared papers)Michael Jarman (2 shared papers)J.C. Reubi (1 shared paper)J D Teale (1 shared paper)
- Journals
- British Journal of Cancer (10 papers)Thorax (2 papers)Cancer Research (2 papers)Investigational New Drugs (1 paper)The Breast (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
IE Smith
17 papers receiving 439 citations
Peers
Comparison fields: 5 of 66
- Oncology 190
- Pulmonary and Respiratory Medicine 155
- Genetics 117
- Cancer Research 44
- Toxicology 8
Countries citing papers authored by IE Smith
This map shows the geographic impact of IE Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by IE Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites IE Smith more than expected).
Fields of papers citing papers by IE Smith
This network shows the impact of papers produced by IE Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by IE Smith. The network helps show where IE Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside IE Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 144 | |
| 2 | 1991 | 69 | |
| 3 | 1993 | 65 | |
| 4 | 1991 | 33 | |
| 5 | 1997 | 28 | |
| 6 | 1996 | 27 | |
| 7 | 1996 | 23 | |
| 8 | 1989 | 21 | |
| 9 | 1987 | 21 | |
| 10 | 1996 | 17 | |
| 11 | 1992 | 6 | |
| 12 | 1987 | 3 | |
| 13 | 1995 | 2 | |
| 14 | 2011 | 1 | |
| 15 | 2011 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2013 | 1 | |
| 18 | PHASE-I CLINICAL-TRIAL OF CB3717 ((N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID) | 1984 | 0 |
About IE Smith
IE Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Molecular Biology, having authored 18 papers that have together received 463 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Research Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (190 citations), Pulmonary and Respiratory Medicine (155 citations), Genetics (117 citations), Cancer Research (44 citations) and Toxicology (8 citations). IE Smith has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Mitch Dowsett, S.E. Ashley, K. Priest, MC Nicolson, J M Shneerson, Michael Jarman, J.C. Reubi, J D Teale, Jeremy Millar and S. Johnston. Their work appears in journals such as British Journal of Cancer, Thorax, Cancer Research, Investigational New Drugs and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.